Figure 6.
Scatter plot of change in the UACR versus change in the sUA from baseline at week 12. Data are presented for the modified intention-to-treat population (n=129): TMX-049 200 mg (n=44), TMX-049 40 mg (n=43), and placebo (n=42).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.